Edward M. Basile

CIK: 0001773661

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (46.2%)

Position reduction

Option Exercises (M)5 (38.5%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TMDX

TransMedics Group, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

TMDX
TransMedics Group, Inc.
May 20, 2026
Award(A)
Direct
2.9K shares-
TMDX
TransMedics Group, Inc.
Oct 29, 2025
Sale(S)
Direct
4.1K shares at avg. $130.45$540K
TMDX
TransMedics Group, Inc.
Oct 29, 2025
Exercise(M)
Direct
4.1K shares at avg. $0.70$3K
TMDX
TransMedics Group, Inc.
Aug 4, 2025
Exercise(M)
Direct
4.1K shares at avg. $0.70$3K
TMDX
TransMedics Group, Inc.
Aug 4, 2025
Sale(S)
Direct
4.1K shares at avg. $125.51$520K
TMDX
TransMedics Group, Inc.
May 27, 2025
Sale(S)
Direct
5K shares at avg. $126.45$632K
TMDX
TransMedics Group, Inc.
May 27, 2025
Exercise(M)
Direct
5K shares at avg. $0.70$4K
TMDX
TransMedics Group, Inc.
May 22, 2025
Award(A)
Direct
2.1K shares-
TMDX
TransMedics Group, Inc.
May 9, 2025
Exercise(M)
Direct
6K shares at avg. $0.70$4K
TMDX
TransMedics Group, Inc.
May 9, 2025
Sale(S)
Direct
6K shares at avg. $115.63$694K
TMDX
TransMedics Group, Inc.
Nov 5, 2024
Exercise(M)
Direct
6.8K shares at avg. $28.12$190K
TMDX
TransMedics Group, Inc.
Nov 5, 2024
Sale(S)
Direct
5.3K shares at avg. $83.35$441K
TMDX
TransMedics Group, Inc.
Nov 5, 2024
Sale(S)
Direct
1.5K shares at avg. $84.30$123K

		Type	Shares	Price		Ownership
May 20, 2026	TMDX TransMedics Group, Inc.	Award(A)	2,922	-	$0	Direct
Oct 29, 2025	TMDX TransMedics Group, Inc.	Sale(S)	4,142	$130.45	$540,324	Direct
Oct 29, 2025	TMDX TransMedics Group, Inc.	Exercise(M)	4,142	$0.70	$2,899	Direct
Aug 4, 2025	TMDX TransMedics Group, Inc.	Exercise(M)	4,143	$0.70	$2,900	Direct
Aug 4, 2025	TMDX TransMedics Group, Inc.	Sale(S)	4,143	$125.51	$519,988	Direct
May 27, 2025	TMDX TransMedics Group, Inc.	Sale(S)	5,000	$126.45	$632,250	Direct
May 27, 2025	TMDX TransMedics Group, Inc.	Exercise(M)	5,000	$0.70	$3,500	Direct
May 22, 2025	TMDX TransMedics Group, Inc.	Award(A)	2,134	-	-	Direct
May 9, 2025	TMDX TransMedics Group, Inc.	Exercise(M)	6,000	$0.70	$4,200	Direct
May 9, 2025	TMDX TransMedics Group, Inc.	Sale(S)	6,000	$115.63	$693,780	Direct
Nov 5, 2024	TMDX TransMedics Group, Inc.	Exercise(M)	6,750	$28.12	$189,810	Direct
Nov 5, 2024	TMDX TransMedics Group, Inc.	Sale(S)	5,296	$83.35	$441,422	Direct
Nov 5, 2024	TMDX TransMedics Group, Inc.	Sale(S)	1,454	$84.30	$122,572	Direct

1-13 of 13 transactions

About Basile Edward M

Basile Edward M (SEC CIK 0001773661) files insider reports with the SEC as Director of TransMedics Group, Inc. (TMDX).

Signal8 holds 7 ownership filings by Basile Edward M, all Form 4s, filed between Nov 7, 2024 and May 22, 2026. Those filings report 13 transactions, from Nov 5, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Basile Edward M's filings is in ANDOVER, MA.

Recent filings by Basile Edward M

May 20, 2026: Grant or award of TMDX shares (Form 4, code A).
Oct 29, 2025: Open-market sale of TMDX shares (Form 4, code S).
Oct 29, 2025: Option exercise of TMDX shares (Form 4, code M).
Aug 4, 2025: Option exercise of TMDX shares (Form 4, code M).
Aug 4, 2025: Open-market sale of TMDX shares (Form 4, code S).

Other insiders filing for TransMedics Group, Inc. (TMDX)

Araujo Fernando N.
Weill David, Director
TOBIN JAMES R, Director
Corcoran Nicholas
Hernandez Gerardo, Chief Financial Officer
Hassanein Waleed H, President & CEO

How to read Form 4 transaction codes